MRMDOTCinactive

MARIMED INC.

Healthcare·Healthcare·Norwood, MA, United States·CEO: Mr. Jon R. Levine
5.4/10

BioSniper Score

Based on 3 of 6 signals

Limited data coverage

Market Cap

$27.9M

Cash Runway

4.7 mo

Lead Asset

Next Catalyst

Go deeper on MARIMED INC. with Spotter

Ask follow-up questions and run a full multi-agent deep dive on MRMD — live, with citations.

Ask Spotter

Score breakdownBased on 3 of 6 signals · derived from public data

No clinical pipeline tracked — this score reflects financial & catalyst signals only.

Cash Runway1.3

4.7 months

Financial Health5.0

OCF $949K · Net income -$4M · Debt/OCF 20.5×

Pipeline MaturityN/A

No tracked pipeline phase

Pipeline BreadthN/A

No tracked pipeline candidates

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider Signal10.0

4 buys · 0 sells (180d)

Key Financialsas of March 31, 2026

Cash

$7.9M

Quarterly Burn

$15.2M

Revenue

$39.5M

Free Cash Flow

$576K

Total Liabilities

$147.7M

Current Ratio

0.95

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Nov 2026
Today~7 mo out
Catalyst within runway

Commercialization & Governance

Commercialization

Launch Markets
Massachusetts
Delaware
Illinois
Maryland
Ohio
Pennsylvania
New York
Commercial Strategy
We utilize dedicated sales teams to sell our products to wholesale buyers representing the dispensaries operated by other cannabis license holders. We deploy a variety of marketing strategies to drive the sales of our products, including customer loyalty programs, digital advertising, in-store displays and public relations.

Governance

Board Size
4

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

1

Total value held

$7

HolderSharesValue
game plan financial advisors, llc100$7

Frequently asked questions

Who is the CEO of MARIMED INC.?

Mr. Jon R. Levine is the chief executive officer of MARIMED INC. (MRMD).

Where is MARIMED INC. headquartered?

MARIMED INC. (MRMD) is headquartered in Norwood, MA, United States.

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.

Get the full picture on MARIMED INC.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.